Sequences within the gag gene of feline immunodeficiency virus (FIV) are important for efficient RNA encapsidation

Virus Research

Volumn 93, Issue 2, 2003, Pages 199-209

  Browning, Matthew T ^a   Mustafa, Farah ^b   Schmidt, Russell D ^a   Lew, Kathy A ^a   Rizvi, Tahir A ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Feline immunodeficiency virus; gag; Human gene therapy; Packaging signal; Retroviral vectors; RNA packaging

Indexed keywords

GAG PROTEIN;

5' UNTRANSLATED REGION; ARTICLE; FELINE IMMUNODEFICIENCY VIRUS; GENE SEQUENCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA PACKAGING; RNA PROCESSING; RNA STABILITY; RNA STRUCTURE; VIRUS CAPSID;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS;

EID: 0038695075     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(03)00098-4     Document Type: Article

References (48)

1. Adam M.A., Miller A.D. Identification of a signal in murine retrovirus that is sufficient for packaging of non-retroviral RNA into virions. J. Virol. 62:1988;3802-3806.
2. Armentano D., Yu S.-F., Kantoff P.W., von Ruden T., Anderson W.F., Gilboa E. Effect of internal viral sequences on the utility of retroviral vectors. J. Virol. 61:1987;1647-1650.
3. Banks J.D., Yeo A., Green K., Cepeda F., Linial M.L. A minimal avian retroviral packaging sequence has a complex structure. J. Virol. 72:1998;6190-6194.
4. Bender M.A., Palmer T.D., Galinas R.E., Miller A.D. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J. Virol. 61:1987;1639-1646.
5. Bray M., Prasad S., Dubay J.W., Hunter E., Jeang K.-T., Rekosh D., Hammarskjold M.J. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc. Natl. Acad. Sci. USA. 4:1994;1256-1260.
6. Browning M.T., Schmidt R.D., Lew K.A., Rizvi T.A. Primate and feline lentiviral vector RNA packaging and propagation by heterologous lentiviral virions. J. Virol. 75:2001;5129-5140.
7. Browning, M.T., Mustafa, F., Schmidt, R.D., Lew, K.A., Rizvi, T.A., 2003. Delineation of sequences important for efficient FIV RNA packaging. J. Gen. Virol. 84, 621-627.
8. Buchschacher G.L., Panganiban A.T. Human immunodeficiency virus vectors for inducible expression of foreign genes. J. Virol. 66:1992;2731-2739.
9. Bukovsky A.A., Song J., Naldini L. Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells. J. Virol. 73:1999;7087-7092.
10. Burns C.C., Moser M., Banks J., Alderete J.P., Overbaugh J. Identification and deletion of sequences required for feline leukemia virus RNA packaging and construction of a high-titer feline leukemia virus packaging cell line. Virology. 222:1996;14-20.
11. Dull T., Zufferey R., Kelly M., Mandel R.J., Nguyen M., Trono D., Naldini L. A third generation of lentivirus vector with a conditional packaging system. J. Virol. 72:1998;8463-8471.
12. Harrich D., Hooker C.W., Parry E. The human immunodeficiency virus type 1 TAR RNA upper stem-loop plays distinct roles in reverse transcription and RNA packaging. J. Virol. 74:2000;5639-5646.
13. Harrison G.P., Hunter E., Lever A.M.L. Secondary structure model of the Mason-Pfizer monkey virus 5′ leader sequence: identification of a structural motif common to a variety of retroviruses. J. Virol. 69:1995;2175-2186.
14. Hayashi T., Shioda T., Iwakura Y., Shibuta H. RNA packaging signal of human immunodeficiency virus type 1. Virology. 188:1992;590-599.
15. Helga-Maria C., Hammarskjöld M.J., Rekosh D. An intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA. J. Virol. 73:1999;4127-4135.
16. Johnston J.C., Gasmi M., Lim L.E., Elder J.H., Yee J.-K., Jolly D.J., Campbell K.P., Davidson B.L., Sauter S. Minimum requirement for efficient transduction of dividing and non-dividing cells by feline immunodeficiency virus vectors. J. Virol. 73:1999;4991-5000.
17. Kaye J.F., Lever A.M.L. Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation. J. Virol. 73:1999;3023-3031.
18. Lever A.M.L. HIV RNA packaging and lentivirus-based vectors. Adv. Pharmacol. 48:2000;1-28.
19. Luban J., Goff S.P. Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA. J. Virol. 68:1994;3784-3793.
20. Maldarelli F., Martin M.A., Strebel K. Identification of post-transcriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. J. Virol. 65:1991;5732-5743.
21. Mansky L.M., Wisniewski R.M. The bovine leukemia virus encapsidation signal is composed of RNA secondary structures. J. Virol. 72:1998;3196-3204.
22. Mansky L.M., Krueger A.E., Temin H.M. The bovine leukemia virus encapsidation signal is discontinuous and extends into the 5′-end of the gag gene. J. Virol. 69:1995;3282-3289.
23. McBride M.S., Panganiban A.T. The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures. J. Virol. 70:1996;2963-2973.
24. McBride M.S., Panganiban A.T. Position dependence of functional hairpins important for human immunodeficiency virus type 1 encapsidation in vivo. J. Virol. 71:1997;2050-2058.
25. McBride M.S., Schwartz M.D., Panganiban A.T. Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation. J. Virol. 71:1997;4544-4554.
26. McCann E.M., Lever A.M.L. Location of cis-acting signals important for RNA encapsidation in the leader sequence of human immunodeficiency virus type 2. J. Virol. 71:1997;4133-4137.
27. Milan D., Nicolas J.-F. Activator-dependent and activator-independent defective recombinant retroviruses from bovine leukemia virus. J. Virol. 65:1991;1938-1945.
28. Miller A.D., Trauber D.R., Buttimore C. Factors involved in the production of helper virus-free retrovirus vector. Somat. Cell Mol. Genet. 12:1986;175-183.
29. Miyoshi H., Blomer U., Takahashi M., Gage F.H., Verma I.M. Development of a self-inactivating lentivirus vector. J. Virol. 72:1998;8150-8157.
30. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., Trono D. In vivo gene delivery and stable transduction of non-dividing cells by a lentiviral vector. Science. 272:1996;263-267.
31. Palmer T.D., Hock R.A., Osborne W.R.A., Miller A.D. Efficient retrovirus-medicated transfer and expression of a human adenosine deaminase gene in diploid skin fibroblasts from an adenosine deaminase-deficient human. Proc. Natl. Acad. Sci. USA. 84:1987;1055-1059.
32. Parolin C., Dorfman T., Palu G., Gottlinger H., Sodroski J. Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes. J. Virol. 68:1994;3888-3895.
33. Poeschla E., Gilbert J., Li X., Huang S., Ho A., Wong-Staal F. Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of non-dividing human cells by HIV-2-based lentivirus vectors. J. Virol. 72:1998;6527-6536.
34. Poeschla E.M., Wong-Staal F., Looney D.J. Efficient transduction of non-dividing cells by feline immunodeficiency virus lentiviral vectors. Nat. Med. 4:1998;354-357.
35. Rizvi T.A., Panganiban A.T. Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles. J. Virol. 67:1993;2681-2688.
36. Rizvi T.A., Schmidt R.D., Lew K.A., Keeling M.E. Rev/RRE-independent Mason-Pfizer monkey virus - constitutive transport element-dependent propagation of SIVmac 239 vectors using a single round of replication assay. Virology. 222:1996;457-463.
37. Rizvi T.A., Lew K.A., Murphy E.C. Jr., Schmidt R.D. Role of Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) in the propagation of MPMV vectors by genetic complementation using homologous/heterologous env genes. Virology. 224:1996;517-532.
38. Rizvi T.A., Schmidt R.D., Lew K.A. Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) functions in a position-dependent manner. Virology. 236:1997;118-129.
39. Schmidt, R.D., Mustafa, F., Lew, K.A., Browning, M.T., Rizvi, T.A., in press. Sequences both within the 5′-untranslated region and the gag gene are important for efficient encapsidation of Mason-Pfizer monkey virus RNA. Virology.
40. Schwartz S., Felber B.K., Pavlakis G.N. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decreases RNA stability and inhibit expression in the absence of Rev protein. J. Virol. 66:1992;150-159.
41. Sorge J., Ricci W., Hughes S.H. cis-acting RNA packaging locus in the 115-nucleotide direct repeat of Rous sarcoma virus. J. Virol. 48:1983;667-675.
42. Swanstrom R., Wills J.W. Synthesis, assembly and processing of viral proteins. Coffin J.M., Hughes S.H., Varmus H.E. Retroviruses. 1997;289-294 Cold Spring Harbor Laboratory Press, New York.
43. Talbott R.T., Sparger E.E., Lovelace K.M., Fitch W.M., Pedersen N.C., Luciw P.A., Elder J.H. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 86:1989;5743-5747.
44. Tan W., Felber B.K., Zolotukhin A.S., Pavlakis G.N., Schwartz S. Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1. J. Virol. 69:1995;5607-5620.
45. Watanabe S., Temin H.M. Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5′ long terminal repeat and the start of the gag gene. Proc. Natl. Acad. Sci. USA. 79:1982;5986-5990.
46. Yu S.S., Kim J.-M., Kim S. The 17 nucleotides downstream from the env gene stop codon are important for murine leukemia virus packaging. J. Virol. 74:2000;8775-8780.
47. Zufferey R., Dull T., Mandel R.J., Bukovsky A., Quiroz D., Naldini L., Trono D. Self-inactivating lentivirus vectors for safe and efficient in vivo gene delivery. J. Virol. 72:1998;9873-9880.
48. White, S.M., Renda, M., Nam, N.-Y., Klimatcheva, E., Zhu, Fisk, J., Halterman, M., Rimel, B., Federoff, H., Pandya, S., Rosenblatt, J.D., Planelles, V., 1999. Lentivirus vectors using human and similar immunodeficiency virus elements. J. Virol. 73, 2832-2840.